Osteonecrosis (ON) is a well-known complication in patients with systemic lupus erythema tosus (SLE) often associated with steroid therapy. In a cohort of 280 SLE patients followed over the last 10 years, seven patients developed symptomatic ON, one of them after septic arthritis of the hip. Two other patients developed ON several years after discontinuing steroids. One patient developed ON of both humeral and femoral heads within a few months after the diagnosis of SLE. When we compared the cumulative steroid doses taken by our patients with those described in other reports (43 700 mg and 45 300 mg, respectively), our patients received less steroids (38 834 mg). We found no increased fre quency of Raynaud's phenomenon, leukopenia, anti-phospholipid antibodies, or a flare of SLE activity in our patients with ON, factors which have been reported to be associated with ON. Various pathogenic mechanisms, which could lead to ON in SLE patients are discussed.
Mankin HJNontraumatic necrosis of bone (osteonecrosis). N Engl J Med1992; 326 (22): 1473-1479.
2.
Dubois EL, Cozen L.Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus . J Am Med Assoc1960; 174: 966-984.
3.
Bergstein JM , Wiens C., Fish AJ, Vernier RL, Michael A.Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. J Paediatr1974; 85: 31-35.
4.
Hurley RM, Steinberg RH, Patriquim H., Drummond KNAvascular necrosis of the femoral head in childhood systemic lupus erythematosus . Can Med Assoc J1974; 111: 781-784.
5.
Smith FE, Sweet DE, Brunner CM, Davis JSAvascular necrosis in SLE - an apparent predilection for young patients . Ann Rheum Dis1976; 35: 227-232.
6.
Dubois ELAvascular (aseptic) necrosis associated with SLE. In: Dubois EL (ed) Lupus erythematosus. Los AngelesUniversity of Southern California Press : Los Angeles, 1974, pp 332-342.
7.
Velayos EE, Leidhold JD, Smyth CJArthropathy associated with steroid therapy. Ann Intern Med1966; 64: 759-771.
8.
Klipper AR, Stevens MB, Zizic, TM, Hungerford DSIschemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 1976: 55: 251-257.
9.
Zizic TM, Marcoux C., Hungerford DS, Dansereau J-V., Stevens MBCorticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med1985 ; 79: 596-604.
10.
Boettcher WG , Bonfiglio M., Hamilton HH, Sheets RF, Smith K.Nontraumatic necrosis of the femoral head . J Bone Joint Surg1970 ; 52: 312-321.
11.
Jones JP, Engelmann EP, Steinbach HLFat embolization as a possible mechanism producing avascular necrosis . Arthr Rheum1965; 8: (abstract 449).
12.
Abeles M., Weiner ES, Parke A., Wilson D.The association of osteonecrosis in SLE with anticardiolipin antibodies . Arthr Rheum1991; 34 (suppl.): R39.
13.
Asherson RA , Liote F., Page B., Meyer O., Buchanan N., Khamashta MA, Jungers P., Hughes Grv.Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol1993; 20: 284-288.
14.
Migliaresi S., Picillo U., Ambrosone L., Di Palma G., Mallozzi M., Tesone ER, Tirri G.Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus1994; 3: 37-41.
15.
Nagasawa K. , Tsukamoto H., Tada Y., Mayumi T., Satoh H., Onitsuka H., Kuwabara Y., Niho Y.Imaging studies on the mode of development and changes in avascular necrosis of the femoral head in systemic lupus erythematosus: long-term observations. Br J Rheumatol1994 ; 33: 343-347.
Tan EM, Cohen AS, Fries JFThe 1982 revised criteria for the classification of systemic lupus erythematosus . Arthr Rheum1982; 25: 1271-1277.
18.
Vitali C., Bencivelli W., Isenberg DA, Smolen JS, Snaith ML, Sciuto M., Neri R., Bombardieri S. and the EuropeanStudy Group for disease activity in SLE. Disease activity in systemic lupus erythematosus: report of the consensus study group of the European Workshop for rheumatology research II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheum1992; 10: 341-347.
19.
Nilsen KHSystemic lupus erythematosus and avascular bone necrosis. N Z Med J1977; 8: 472-475.
20.
Zizic TMOsteonecrosis. Curr Opp Rheum1991 ; 3: 481-489.
21.
Dimant J., Ginzler EM, Diamond HS, Schlesinger M., Marino CT, Weiner M., Kaplan D.Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol1978; 5: 136-141.
22.
Abeles M., Urmann JD, Rothfield N.Aseptic necrosis of bone in systemic lupus erythematosus: relationship to corticosteroid therapy. Arch Intern Med1978 ; 138: 750-754.
23.
Massardo E. , Jacobelli S., Leissner M., Gonzales M., Villarroel L., Rivero S.High dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus . Lupus1992; 1: 401-405.
24.
Felson DT, Anderson JJA cross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet1987 ; 18: 902-905.
25.
Fishel B., Caspi D., Eventov I., Avrahami E., Yaron M.Multiple osteonecrotic lesions in systemic lupus erythematosus. J Rheumatol1987 ; 14: 601-604.
26.
Nagasawa K. , Ishij Y., Mayumi T., Tada Y., Ueda A., Yamauchi Y., Kusaba T., Niho Y.Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities . Ann Rheum Dis1989; 48: 672-676.
27.
Masuyama J. , Murata M., Yoshio T., Takeda A., Kuriyama M., Sumiya M., Kano S.A systemic lupus erythematosus patient with multiple aseptic bone necroses, thrombosis of superior mesenteric artery and anti-phospholipid antibody. Ryumachi1992; 32: 502-507.
